Chimin Health Management Co., Ltd. Stock price

Equities

603222

CNE100002193

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
6.35 CNY 0.00% Intraday chart for Chimin Health Management Co., Ltd. -7.03% -20.72%
Sales 2021 1.1B 152M Sales 2022 837M 116M Capitalization 4.17B 578M
Net income 2021 148M 20.49M Net income 2022 34M 4.71M EV / Sales 2021 6 x
Net Debt 2021 317M 43.83M Net cash position 2022 49.5M 6.85M EV / Sales 2022 4.93 x
P/E ratio 2021
41.8 x
P/E ratio 2022
125 x
Employees 1,851
Yield 2021
0.49%
Yield 2022
0.23%
Free-Float 55.45%
More Fundamentals * Assessed data
Dynamic Chart
Tranche Update on Chimin Health Management Co., Ltd.'s Equity Buyback Plan announced on July 25, 2023. CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Chimin Health Management Secures Exclusive Rights to Japanese Cell Therapy Tech MT
Chimin Health Management Co., Ltd.(XSSC:603222) added to S&P Global BMI Index CI
Chimin Health Management Co., Ltd. announces an Equity Buyback for CNY 120 million worth of its shares. CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Chimin Health Management Co., Ltd. authorizes a Buyback Plan. CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Chimin Health Management Co., Ltd. announced that it has received CNY 489.999998 million in funding CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Chimin Health Management Co., Ltd. announced that it expects to receive CNY 900 million in funding CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
More news
1 week-7.03%
Current month+2.25%
1 month+5.31%
3 months-19.72%
6 months-36.31%
Current year-20.72%
More quotes
1 week
6.28
Extreme 6.28
6.71
1 month
6.02
Extreme 6.02
6.88
Current year
4.70
Extreme 4.7
8.12
1 year
4.70
Extreme 4.7
14.37
3 years
4.70
Extreme 4.7
16.28
5 years
4.70
Extreme 4.7
41.07
10 years
3.79
Extreme 3.7857
41.07
More quotes
Managers TitleAgeSince
President 44 08-03-31
Chief Tech/Sci/R&D Officer 47 22-11-14
Director/Board Member 42 18-04-10
Members of the board TitleAgeSince
Director/Board Member 67 19-10-15
Chairman 46 -
President 44 08-03-31
More insiders
Date Price Change Volume
24-03-28 6.35 0.00% 7,434,613
24-03-27 6.35 -2.31% 5,755,520
24-03-26 6.5 +0.62% 4,488,100
24-03-25 6.46 -3.15% 5,906,420
24-03-22 6.67 -2.34% 7,804,700

End-of-day quote Shanghai S.E., March 27, 2024

More quotes
Chimin Health Management Co., Ltd., formerly Zhejiang Chimin Pharmaceutical CO., Ltd, is primarily engaged in the research, development, manufacture and sale of infusion and injection and puncture machinery products. The Company primarily produces Non Polyvinyl chloride (PVC) soft bag infusion products, plastic bottle infusion products, as well as injection and puncture machinery products, including safety syringe, sterile syringes and infusion sets. The Company distributes its products within domestic market and to overseas markets.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Chimin Health Management Co., Ltd. - Shanghai S.E.